J Clin Endocrinol Metab November 2015 PMID 26444994

Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline.

Cynthia A Stuenkel, Susan R Davis, Anne Gompel, Mary Ann Lumsden, M Hassan Murad, JoAnn V Pinkerton, Richard J Santen

Download social card

Mentions

Peak: 1 in Feb 2021

across 5 sources since Feb 2021

Extended reach

9,936

potential audience

Total likes

224

Video views

9,216

Mentions per month

Feb 2021 – Nov 2025

Where it's discussed

News30 articles
YouTube3 videos
Facebook3 posts
X / Twitter2 posts
Blogs2 articles

AI synopsis

What people are saying

Discussions reflect a general acceptance of the guideline, with comments like emphasizing hormone therapy as the most effective for menopause symptoms, and notes about the importance of evaluating risks, which indicates moderate engagement. The tone is pragmatic but not deeply exploratory, with words like 'guideline' and 'recommendations' contributing to a neutral yet supportive sentiment.

AgreementModerate agreement

Most discussions acknowledge and support the clinical importance of the guideline, emphasizing its role in guiding menopause treatment decisions.

InterestModerate interest

The discussions show moderate curiosity, with some mentioning specific treatments like hormone therapy and concerns about risks, but overall engagement is not highly enthusiastic.

EngagementNeutral engagement

Participants briefly reference sections of the guideline and its implications, but there is limited in-depth analysis or critical debate.

ImpactModerate impact

The collective tone suggests the guideline influences current clinical considerations and prompts modest shifts in perspectives, indicating some real-world effect.

Abstract in brief

This guideline from the Endocrine Society offers recommendations for managing menopause symptoms, emphasizing the importance of individualized treatment based on a thorough assessment of risks and benefits.
Hormone therapy (MHT) is identified as the most effective option for relieving menopause symptoms like hot flashes, especially for women under 60 or within 10 years of menopause onset, but healthcare providers should carefully evaluate cardiovascular and breast cancer risks beforehand.
The guideline highlights that current evidence does not support using hormone therapy to prevent heart disease, breast cancer, or dementia, and encourages exploring other treatment options for vasomotor symptoms when necessary.

Read the full abstract